Reaction profile

The FDA adverse-event record for nt - hypertrophic concentric cardiomyopathy

Name: NT - hypertrophic concentric cardiomyopathy - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

24 FDA reports name nt - hypertrophic concentric cardiomyopathy, a lower-volume reaction in the CVM extract (VeDDRA 2301). Plate stamps and neighbourhood peers follow.

#2089 of 2,481
by report volume (all reactions): 24
reports citing this reaction: 91.7%
death-coded share: Cat
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. NT - hypertrophic concentric cardiomyopathy has 24 reports now versus 24 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: −0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to NT - hypertrophic concentric cardiomyopathy changes

FDA AER · VeDDRA plate

Code 2301 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-CAT · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 24 reports
DEATH-HOT 91.7%
LOWER-Q #2089/2481
PHOTO-FINISH Acute pancreatitis
SPECIES-CAT Cat · 14
DRUG-LEAD Spinosad · 5
DESK-WIDE 14 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Acute pancreatitis (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around NT - hypertrophic concentric cardiomyopathy

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around NT - hypertrophic concentric cardiomyopathy

NT - hypertrophic concentric cardiomyopathy: high death-coded share in the FDA AER plate

Signature read: NT - hypertrophic concentric cardiomyopathy's 91.7% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 24 named reports in the openFDA extract. Death-coded share is upper-third: 22 of 24 reports (91.7% of named reports). Nearest volume peer: Acute pancreatitis (±0 reports). Lead species Cat (14). Lead co-reported drug Spinosad (5).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cat 14

Dog 10

Breeds Most Affected

Domestic Shorthair 10

Domestic Longhair 2

American Shorthair 1

Doberman Pinscher 1

Pug 1

Japanese Chin (Spaniel) 1

Basenji 1

Boxer (German Boxer) 1

Beagle 1

Poodle - Toy 1

Associated Drugs

Spinosad 5

Afoxolaner 3

Fluralaner Spot-On Solution 3

Maropitant Citrate 2

Cefovecin 2

Furosemide 2

Lotilaner 2

Fluralaner/Moxidectin Spot-On 2

Selamectin;Sarolaner 2

Methylprednisolone Acetate 1

Epinephrine 1

Famotidine 1

Atropine 1

Albuterol 1

Dexamethasone Sodium Phosphate 1

Propofol 1

Methylprednisone Acetate 1

Prescription Veterinary Diet 1

Milbemycin Oxime, Lufenuron 1

Melarsomine Dihydrochloride Injection 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for NT - hypertrophic concentric cardiomyopathy (#2089 of 2,481 by report volume); death-coded 91.7%. PlainBreed reaction plate · death-coded share stamp 91.7% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →